SRV’s 2025 will still be driven by non-residential volumes while we expect that the residential pick...
Today (16 December), Elanders announced that it has implemented structural measures regarding its ro...
Mendus continues to make headway with its lead programme assessing cancer vaccine vididencel as a po...
Today, Medivir announced its application to start a phase II study in liver cancer was approved by t...
Addlife ökade omsättningen med 1% (3% organiskt) till 2 344 MSEK under tredje kvartalet, jämfört med...
Pharma Equity Group (“PEG” or “the Company”) announced on Friday, December the 13th, the board of di...
Tethys Oil har under hösten fått ett bud på 58,70 kr per aktie som ligger i princip mitt i intervall...
Verve Group is emerging as a strong adtech player, with particular strength in mobile and growing po...
Redeye comments on the positive news that Emcitate has received a positive CHMP opinion for MCT8 def...
Redeye takes a positive stance towards Hanza's acquisition of Leden.
Redeye comments on today’s news, where Nitro Games continues to demonstrate its strategy of being a ...
Redeye was not surprised to see that Powercell last night carried out a directed share issue of SEK1...
We lower our net sales and EBIT forecast by 1% for 2024.
Redeye updates its estimates for 2025 after the partnership announcement with the South Korean free-...
Aspo downgraded guidance as ESL’s demand hasn’t picked up as fast as might have been expected earlie...
